ReP USP - Resultado da busca

Artigo de periodico
New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis (2021)
Burt, Richard K.; Muraro, Paolo A.; Farge, Dominique; Oliveira, Maria Carolina; Snowden, John A.; Saccardi, Riccardo; Han, Xiaoqiang; Quigley, Kathleen; Bueno, Valquiria; Frasca, Daniela; Fedorenko, Denis; Burman, Joachim
Source: Bone Marrow Transplantation. Unidade: FMRP
Subjects: DOENÇAS AUTOIMUNES, DOENÇA ENXERTO-HOSPEDEIRO, CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, ESCLEROSE MÚLTIPLA, TRANSPLANTE AUTÓLOGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURT, Richard K. et al. New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplantation, v. 56, n. 7, p. 1509-1517, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41409-021-01277-y. Acesso em: 13 ago. 2024.
APA
Burt, R. K., Muraro, P. A., Farge, D., Oliveira, M. C., Snowden, J. A., Saccardi, R., et al. (2021). New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplantation, 56( 7), 1509-1517. doi:10.1038/s41409-021-01277-y
NLM
Burt RK, Muraro PA, Farge D, Oliveira MC, Snowden JA, Saccardi R, Han X, Quigley K, Bueno V, Frasca D, Fedorenko D, Burman J. New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis [Internet]. Bone Marrow Transplantation. 2021 ; 56( 7): 1509-1517.[citado 2024 ago. 13 ] Available from: https://doi.org/10.1038/s41409-021-01277-y
Vancouver
Burt RK, Muraro PA, Farge D, Oliveira MC, Snowden JA, Saccardi R, Han X, Quigley K, Bueno V, Frasca D, Fedorenko D, Burman J. New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis [Internet]. Bone Marrow Transplantation. 2021 ; 56( 7): 1509-1517.[citado 2024 ago. 13 ] Available from: https://doi.org/10.1038/s41409-021-01277-y
Artigo de periodico
Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial (2019)
Burt, Richard K. ; Balabanov, Roumen; Burman, Joachim ; Sharrack, Basil; Snowden, John A.; Oliveira, Maria Carolina ; Fagius, Jan; Rose, John; Nelson, Flavia; Barreira, Amilton Antunes; Carlson, Kristina; Han, Xiaoqiang; Moraes, Daniela; Morgan, Amy; Quigley, Kathleen; Yaung, Kimberly; Buckley, Regan; Alldredge, Carri; Clendenan, Allison; Calvario, Michelle A.; Henry, Jacquelyn; Jovanovic, Borko; Helenowski, Irene B.
Source: Jama. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURT, Richard K. et al. Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial. Jama, v. 321, n. 2, p. 165-174, 2019Tradução . . Disponível em: https://doi.org/10.1001/jama.2018.18743. Acesso em: 13 ago. 2024.
APA
Burt, R. K., Balabanov, R., Burman, J., Sharrack, B., Snowden, J. A., Oliveira, M. C., et al. (2019). Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial. Jama, 321( 2), 165-174. doi:10.1001/jama.2018.18743
NLM
Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA, Carlson K, Han X, Moraes D, Morgan A, Quigley K, Yaung K, Buckley R, Alldredge C, Clendenan A, Calvario MA, Henry J, Jovanovic B, Helenowski IB. Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial [Internet]. Jama. 2019 ; 321( 2): 165-174.[citado 2024 ago. 13 ] Available from: https://doi.org/10.1001/jama.2018.18743
Vancouver
Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA, Carlson K, Han X, Moraes D, Morgan A, Quigley K, Yaung K, Buckley R, Alldredge C, Clendenan A, Calvario MA, Henry J, Jovanovic B, Helenowski IB. Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial [Internet]. Jama. 2019 ; 321( 2): 165-174.[citado 2024 ago. 13 ] Available from: https://doi.org/10.1001/jama.2018.18743
Artigo de periodico
Autologous haematopoietic stem cell transplantation reduces abnormalities in the expression of immune genes in multiple sclerosis (2015)
Sousa, Alessandra de Paula; Malmegrim, Kelen C.; Panepucci, Rodrigo A.; Brum, Doralina S.; Barreira, Amilton Antunes; Santos, Antônio Carlos dos; Araújo, Amélia Goes; Covas, Dimas Tadeu; Oliveira, Maria C.; Moraes, Daniela A.; Pieroni, Fabiano; Barros, George M.; Simões, Belinda Pinto; Nicholas, Richard; Burt, Richard K.; Voltarelli, Julio Cesar; Muraro, Paolo A.
Source: Clinical Science. Unidade: FMRP
Subjects: EXPRESSÃO GÊNICA, REGULAÇÃO GÊNICA, CÉLULAS-TRONCO (TRANSPLANTE), ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Alessandra de Paula et al. Autologous haematopoietic stem cell transplantation reduces abnormalities in the expression of immune genes in multiple sclerosis. Clinical Science, v. 128, n. 2, p. 111-120, 2015Tradução . . Disponível em: https://doi.org/10.1042/CS20140095. Acesso em: 13 ago. 2024.
APA
Sousa, A. de P., Malmegrim, K. C., Panepucci, R. A., Brum, D. S., Barreira, A. A., Santos, A. C. dos, et al. (2015). Autologous haematopoietic stem cell transplantation reduces abnormalities in the expression of immune genes in multiple sclerosis. Clinical Science, 128( 2), 111-120. doi:10.1042/CS20140095
NLM
Sousa A de P, Malmegrim KC, Panepucci RA, Brum DS, Barreira AA, Santos AC dos, Araújo AG, Covas DT, Oliveira MC, Moraes DA, Pieroni F, Barros GM, Simões BP, Nicholas R, Burt RK, Voltarelli JC, Muraro PA. Autologous haematopoietic stem cell transplantation reduces abnormalities in the expression of immune genes in multiple sclerosis [Internet]. Clinical Science. 2015 ; 128( 2): 111-120.[citado 2024 ago. 13 ] Available from: https://doi.org/10.1042/CS20140095
Vancouver
Sousa A de P, Malmegrim KC, Panepucci RA, Brum DS, Barreira AA, Santos AC dos, Araújo AG, Covas DT, Oliveira MC, Moraes DA, Pieroni F, Barros GM, Simões BP, Nicholas R, Burt RK, Voltarelli JC, Muraro PA. Autologous haematopoietic stem cell transplantation reduces abnormalities in the expression of immune genes in multiple sclerosis [Internet]. Clinical Science. 2015 ; 128( 2): 111-120.[citado 2024 ago. 13 ] Available from: https://doi.org/10.1042/CS20140095
Artigo de periodico
Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis (2015)
Burt, Richard K.; Balabanov, Roumen; Han, Xiaoqiang; Sharrack, Basil; Morgan, Amy; Quigley, Kathleen; Yaung, Kim; Helenowski, Irene B.; Javanovic, Borko; Spahovic, Dzemila; Arnautovic, Indira; Lee, Daniel C.; Benefield, Brandon C.; Futterer, Stephen; Oliveira, Maria Carolina; Burman, Joachim
Source: JAMA : The Journal of the American Medical Association. Unidade: FMRP
Subjects: HEMATOPOESE, CÉLULAS-TRONCO, TRANSPLANTES, ESCLEROSE MÚLTIPLA, TERAPÊUTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURT, Richard K. et al. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis. JAMA : The Journal of the American Medical Association, v. 313, n. 3, p. 275-284, 2015Tradução . . Disponível em: https://doi.org/10.1001/jama.2014.17986. Acesso em: 13 ago. 2024.
APA
Burt, R. K., Balabanov, R., Han, X., Sharrack, B., Morgan, A., Quigley, K., et al. (2015). Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis. JAMA : The Journal of the American Medical Association, 313( 3), 275-284. doi:10.1001/jama.2014.17986
NLM
Burt RK, Balabanov R, Han X, Sharrack B, Morgan A, Quigley K, Yaung K, Helenowski IB, Javanovic B, Spahovic D, Arnautovic I, Lee DC, Benefield BC, Futterer S, Oliveira MC, Burman J. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis [Internet]. JAMA : The Journal of the American Medical Association. 2015 ; 313( 3): 275-284.[citado 2024 ago. 13 ] Available from: https://doi.org/10.1001/jama.2014.17986
Vancouver
Burt RK, Balabanov R, Han X, Sharrack B, Morgan A, Quigley K, Yaung K, Helenowski IB, Javanovic B, Spahovic D, Arnautovic I, Lee DC, Benefield BC, Futterer S, Oliveira MC, Burman J. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis [Internet]. JAMA : The Journal of the American Medical Association. 2015 ; 313( 3): 275-284.[citado 2024 ago. 13 ] Available from: https://doi.org/10.1001/jama.2014.17986
Artigo de periodico-carta/editorial
Autologous hematopoietic stem cell transplantation for multiple sclerosis – if confused or hesitant, remember [Editorial]: ‘treat with standard immune suppressive drugs and if no inflammation, no response’ (2012)
Burt, Richard K.; Balabanov, Roumen; Voltarelli, Julio Cesar; Barreira, Amilton Antunes; Burman, Joachim
Source: Multiple Sclerosis Journal. Unidade: FMRP
Subjects: TRANSPLANTES, CÉLULAS-TRONCO, ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURT, Richard K. et al. Autologous hematopoietic stem cell transplantation for multiple sclerosis – if confused or hesitant, remember [Editorial]: ‘treat with standard immune suppressive drugs and if no inflammation, no response’. Multiple Sclerosis Journal. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1177/1352458512442993. Acesso em: 13 ago. 2024. , 2012
APA
Burt, R. K., Balabanov, R., Voltarelli, J. C., Barreira, A. A., & Burman, J. (2012). Autologous hematopoietic stem cell transplantation for multiple sclerosis – if confused or hesitant, remember [Editorial]: ‘treat with standard immune suppressive drugs and if no inflammation, no response’. Multiple Sclerosis Journal. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1177/1352458512442993
NLM
Burt RK, Balabanov R, Voltarelli JC, Barreira AA, Burman J. Autologous hematopoietic stem cell transplantation for multiple sclerosis – if confused or hesitant, remember [Editorial]: ‘treat with standard immune suppressive drugs and if no inflammation, no response’ [Internet]. Multiple Sclerosis Journal. 2012 ; 18( 6): 772-775.[citado 2024 ago. 13 ] Available from: https://doi.org/10.1177/1352458512442993
Vancouver
Burt RK, Balabanov R, Voltarelli JC, Barreira AA, Burman J. Autologous hematopoietic stem cell transplantation for multiple sclerosis – if confused or hesitant, remember [Editorial]: ‘treat with standard immune suppressive drugs and if no inflammation, no response’ [Internet]. Multiple Sclerosis Journal. 2012 ; 18( 6): 772-775.[citado 2024 ago. 13 ] Available from: https://doi.org/10.1177/1352458512442993

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration